Kyoo H. Kim
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
High-dimensional immune profiling of peripheral blood identifies immune correlates of anti-PD-1/PD-L1 resistance in oncogenic driver mutation-positive NSCLC.
Journal: Frontiers in immunology
Published: March 13, 2026
Subtype-Specific Risk and Temporal Dynamics of Brain Metastases in Metastatic Breast Cancer.
Journal: Clinical breast cancer
Published: August 23, 2025
Differential Efficacy of Alpelisib by PIK3CA Mutation Site in Head and Neck Squamous Cell Carcinoma: An Analysis from the KCSG HN 15-16 TRIUMPH Trial.
Journal: Cancer research and treatment
Published: December 11, 2024
Exploring Molecular Genetic Alterations and RAF Fusions in Melanoma: A Belvarafenib Expanded Access Program in Patients with RAS/RAF-Mutant Melanoma.
Journal: The oncologist
Published: November 21, 2023
A phase II study on the efficacy of regorafenib in treating patients with c-KIT-mutated metastatic malignant melanoma that progressed after previous treatment (KCSG-UN-14-13).
Journal: European journal of cancer (Oxford, England : 1990)
Published: June 29, 2023
Impact of Coronavirus Disease 2019 on Gastric Cancer Diagnosis and Stage: A Single-Institute Study in South Korea.
Journal: Journal of gastric cancer
Published: May 17, 2023
A Phase II Trial of Nintedanib in Patients with Metastatic or Recurrent Head and Neck Squamous Cell Carcinoma: In-Depth Analysis of Nintedanib Arm from the KCSG HN 15-16 TRIUMPH Trial.
Journal: Cancer research and treatment
Published: March 03, 2023
Immunogenicity and Safety of Vaccines against Coronavirus Disease in Actively Treated Patients with Solid Tumors: A Prospective Cohort Study.
Journal: Cancer research and treatment
Published: November 23, 2022
First-line pembrolizumab versus dabrafenib/trametinib treatment for BRAF V600-mutant advanced melanoma.
Journal: Journal of the American Academy of Dermatology
Published: May 05, 2022
Inhibition of the bromodomain and extra-terminal family of epigenetic regulators as a promising therapeutic approach for gastric cancer.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: October 30, 2021
p16 methylation is a potential predictive marker for abemaciclib sensitivity in gastric cancer.
Journal: Biochemical pharmacology
Published: August 03, 2020
Regulation of proliferation and invasion by the IGF signalling pathway in Epstein-Barr virus-positive gastric cancer.
Journal: Journal of cellular and molecular medicine
Published: February 22, 2018
Last Updated: 09/26/2026